Caris Life Sciences CAI Growth Metrics (2024-2026)

NASDAQ CAI
$21.68 -1.36 (-5.88%)
As of: Nov 16, 2026 · 11:38 AM EST
Reported Financials

Caris Life Sciences Quarterly Growth Metrics

Periods 9 quarters
Latest Sep 2026

Caris Life Sciences reported revenue growth of 26.99% and asset growth of 27.53% for the quarter ended Sep 2026. These growth metrics cover 9 quarters of results from Sep 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Total Debt (QoQ) 0.74%0.67%0.68%3.03%0.03%
Total Debt Growth (1y) -0.14%5.20%4.46%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 5.38%195.18%92.59%-51.74%-2.11%18.74%39.99%-16.75%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 189.12%168.58%8.04%-21.47%35.47%
Revenue (QoQ) 1.57%27.84%-6.93%50.02%19.53%35.07%-26.19%21.99%4.42%
Revenue Growth (1y) 81.31%113.38%125.44%78.78%45.38%26.99%
Return on Sales [ROS] (QoQ)ROS (QoQ) 711.000.00M0.00M0.00M0.00M0.00M0.00M777.00-320.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 0.01M0.01M0.01M0.01M0.00M-804.00
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ) 442.00-198.00
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.00M0.00M0.00M-213.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M597.00442.00-234.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M941.00575.00-106.00
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 4.37%-1.29%30.87%15.78%6.87%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -6.85%56.11%59.84%
Operating Margin (QoQ) 711.000.00M0.00M0.00M0.00M0.00M0.00M777.00-320.00
Operating Margin Growth (1y) 0.01M0.01M0.01M0.01M0.00M-804.00
Operating Income (QoQ)Op. Inc (QoQ) 9.21%39.11%-56.43%68.96%281.46%170.85%-94.03%409.77%-28.26%
Operating Income Growth (1y)Op. Inc Growth (1y) 73.16%153.65%338.65%109.11%249.68%-40.82%
Net Margin (QoQ) -118.000.00M-0.01M-0.02M0.03M0.00M0.00M-1.00578.00
Net Margin Growth (1y) -0.02M0.01M0.01M0.01M0.03M-568.00
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -2.91%32.95%-105.09%-307.10%104.70%236.92%-100.62%-24.90%2,494.03%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -476.07%126.33%232.30%99.60%99.88%-37.31%
Net Income (QoQ) -2.33%45.45%-177.64%30.02%133.88%236.92%-100.62%-24.90%2,494.03%
Net Income Growth (1y) -8.47%135.92%321.82%99.50%99.11%-37.31%
Net Cash Flow (QoQ)NCF (QoQ) 42.41%20.11%2,199.15%-95.02%25.87%-45.79%-659.20%80.49%
Net Cash Flow Growth (1y)NCF Growth (1y) 148.10%205.13%171.34%-119.00%-174.44%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 10.03%36.65%-62.31%79.34%358.04%222.15%-94.70%607.59%-28.43%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) 80.89%154.81%378.71%109.10%411.56%-13.58%
Income After Tax (QoQ) -2.33%45.45%-177.64%30.02%133.88%236.92%-100.62%-24.90%2,494.03%
Income After Tax Growth (1y) -8.47%135.92%321.82%99.50%99.11%-37.31%
Gross Profit (QoQ) 18.26%59.19%-19.29%99.23%29.75%49.77%-36.02%27.06%1.50%
Gross Profit Growth (1y) 202.72%232.13%212.46%147.71%57.98%23.58%
Gross Margin (QoQ) 617.000.00M-723.000.00M536.00740.000.00M272.00-190.00
Gross Margin Growth (1y) 0.00M0.00M0.00M0.00M543.00-183.00
Free Cash Flow (QoQ)FCF (QoQ) 42.16%17.43%117.35%837.48%-28.27%-43.22%-71.59%-720.37%
Free Cash Flow Growth (1y)FCF Growth (1y) 177.65%196.31%166.22%8.47%-171.78%
FCF Margin (QoQ) 0.00M358.000.00M0.00M0.00M-313.00-800.000.00M
FCF Margin Growth (1y) 0.01M0.00M0.00M-83.000.00M
EPS (Diluted) (QoQ) -2.12%32.67%-104.36%-123.39%101.03%498.89%-100.37%-24.76%2,394.65%
EPS (Diluted) Growth (1y) -213.88%103.16%128.09%99.95%99.97%-36.87%
EPS (Basic) (QoQ) -2.12%32.67%-104.36%-123.39%101.08%468.44%-100.37%-24.76%2,485.55%
EPS (Basic) Growth (1y) -213.88%103.33%128.09%99.95%99.97%-37.70%
EBT (QoQ) -2.33%45.45%-177.64%30.02%133.88%236.92%-100.79%4.66%2,848.21%
EBT Margin (QoQ) -50.000.00M-0.01M0.00M0.01M0.00M0.00M7.00636.00
EBT Margin Growth (1y) 0.00M0.01M0.01M0.01M0.00M-509.00
EBT Growth (1y) -8.47%135.92%321.82%99.37%99.14%-30.63%
EBIT (QoQ) 9.21%39.11%-56.43%68.96%281.46%170.85%-94.03%409.77%-28.26%
EBIT Margin (QoQ) 711.000.00M0.00M0.00M0.00M0.00M0.00M777.00-320.00
EBIT Margin Growth (1y) 0.01M0.01M0.01M0.01M0.00M-804.00
EBIT Growth (1y) 73.16%153.65%338.65%109.11%249.68%-40.82%
EBITDA Margin (QoQ) 591.000.00M0.00M0.00M0.00M0.00M0.00M677.00-326.00
EBITDA Margin Growth (1y) 0.01M0.01M0.01M0.00M0.00M-892.00
Cash from Operations (QoQ)Cash from Ops. (QoQ) 43.94%19.48%123.26%756.55%-28.27%-26.58%-13.38%-178.12%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 189.91%215.05%204.91%290.74%-135.64%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -25.27%-17.42%48.46%-411.90%28.26%-103.18%-1,081.51%85.70%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -288.13%-122.27%-284.60%-8,716.16%-146.23%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 4.76%5.71%2.93%-15.86%-3.70%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 1,119.09%-4.10%-11.85%
Capital Expenditures (QoQ)Capex (QoQ) 25.27%17.42%-48.46%411.90%-28.26%103.18%113.45%-20.86%
Capital Expenditures Growth (1y)Capex Growth (1y) 288.13%122.27%284.60%1,492.71%146.23%
Assets (QoQ) 3.09%14.33%3.26%5.78%2.11%
Assets Growth (1y) 227.48%28.75%27.53%

Caris Life Sciences Growth Metrics API

Pull Caris Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CAI&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY